Kamada (KMDA) Current Leases (2018 - 2026)
Kamada (KMDA) posted quarterly Current Leases of $2.2 million for Q1 2026, up 23.48% year-on-year from $1.8 million in Q1 2025, and up 3.63% on a QoQ basis from $2.1 million in Q4 2025.
Kamada (KMDA) Current Leases (2018 - 2026) Analysis & Trends
Kamada (KMDA) has reported Current Leases for 9 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- Quarterly Current Leases rose 23.48% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 23.48% YoY) and the FY2025 annual result came in at $2.1 million, up 30.04% from the prior year.
- Current Leases grew to $2.2 million in Q1 2026 per KMDA's latest filing, from $2.1 million in the prior quarter.
- Over the last five years, Current Leases for KMDA reached as high as $2.2 million in Q1 2026 and fell as low as $1004.0 in Q3 2022.
- A 5-year average of $1.3 million and a median of $1.5 million in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases tumbled 99.91% — and 2023, when it soared 113246.61%.
- Year by year, Current Leases stood at $1.0 million in 2022, then jumped by 36.22% to $1.4 million in 2023, then advanced by 17.85% to $1.6 million in 2024, then jumped by 30.04% to $2.1 million in 2025, then gained by 3.63% to $2.2 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $2.2 million, $2.1 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 2.12 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.78 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.06 Mn |
| Mar 31, 2023 | 1,438.00 |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 1,004.00 |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 1.18 Mn |
| Jun 30, 2021 | 1.15 Mn |